X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1310) 1310
Publication (80) 80
Book Review (15) 15
Patent (11) 11
Dissertation (5) 5
Newspaper Article (4) 4
Book Chapter (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (898) 898
male (617) 617
female (604) 604
index medicus (588) 588
oncology (566) 566
middle aged (497) 497
aged (489) 489
administration, oral (482) 482
drug combinations (476) 476
s-1 (404) 404
chemotherapy (402) 402
adult (382) 382
tegafur - administration & dosage (381) 381
cancer (355) 355
oxonic acid - administration & dosage (338) 338
antineoplastic combined chemotherapy protocols - therapeutic use (299) 299
5-fluorouracil (282) 282
treatment outcome (248) 248
pharmacology & pharmacy (207) 207
animals (205) 205
tegafur - therapeutic use (196) 196
medicine & public health (192) 192
stomach neoplasms - drug therapy (192) 192
fluorouracil (186) 186
tegafur - adverse effects (186) 186
oxonic acid - therapeutic use (183) 183
oxonic acid - adverse effects (177) 177
aged, 80 and over (176) 176
antimetabolites, antineoplastic - administration & dosage (163) 163
antineoplastic combined chemotherapy protocols - adverse effects (159) 159
capecitabine (157) 157
research (156) 156
care and treatment (154) 154
drug administration schedule (146) 146
antimetabolites, antineoplastic - therapeutic use (145) 145
surgery (145) 145
neoplasm staging (129) 129
stomach neoplasms - pathology (129) 129
oral fluoropyrimidine (127) 127
gastric cancer (124) 124
colorectal cancer (123) 123
metastasis (122) 122
trial (122) 122
carcinoma (119) 119
therapy (117) 117
fluorouracil - administration & dosage (116) 116
oxaliplatin (115) 115
stomach cancer (115) 115
cisplatin (114) 114
deoxycytidine - analogs & derivatives (114) 114
colorectal neoplasms - drug therapy (112) 112
survival rate (110) 110
antineoplastic combined chemotherapy protocols - administration & dosage (109) 109
disease-free survival (109) 109
clinical trials (108) 108
dentistry, oral surgery & medicine (105) 105
adjuvant chemotherapy (95) 95
analysis (95) 95
antimetabolites, antineoplastic - adverse effects (95) 95
chemotherapy, adjuvant (94) 94
cancer research (92) 92
phase-ii (92) 92
antitumor-activity (90) 90
pharmacology/toxicology (90) 90
rats (90) 90
oncology, experimental (87) 87
radiotherapy (87) 87
cisplatin - administration & dosage (85) 85
leucovorin (83) 83
survival (83) 83
retrospective studies (82) 82
antineoplastic agents (81) 81
dose-response relationship, drug (81) 81
prognosis (81) 81
time factors (80) 80
adenocarcinoma - drug therapy (79) 79
antimitotic agents (79) 79
surgical oncology (79) 79
tegafur (79) 79
cancer therapies (77) 77
drug therapy (77) 77
gemcitabine (76) 76
deoxycytidine - administration & dosage (75) 75
health aspects (73) 73
pyridines - administration & dosage (72) 72
mice (69) 69
1st-line treatment (68) 68
follow-up studies (68) 68
oral s-1 (68) 68
phase-ii trial (68) 68
patients (67) 67
toxicity (67) 67
colorectal neoplasms - pathology (66) 66
gastroenterology & hepatology (66) 66
stomach neoplasms - surgery (66) 66
tumors (66) 66
antineoplastic agents - administration & dosage (64) 64
antineoplastic agents - therapeutic use (63) 63
dentistry (63) 63
cancer patients (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1223) 1223
Japanese (122) 122
French (3) 3
Korean (3) 3
Spanish (3) 3
Chinese (2) 2
Russian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Cancer, ISSN 1471-2407, 08/2017, Volume 17, Issue 1, pp. 548 - 7
Background: Metastatic colorectal cancer (mCRC) is a disease of older age, but there is a relative lack of knowledge about effects of chemotherapy in older... 
IRIS | Geriatric assessment | Randomized phase II | Oral | SOX | Metastatic colorectal cancer | Non-intensive | 1ST-LINE TREATMENT | YOUNGER PATIENTS | INTERNATIONAL-SOCIETY | OPEN-LABEL | ONCOLOGY | SCREENING TOOLS | PHASE-3 TRIAL | ELDERLY-PATIENTS | COOPERATIVE-ONCOLOGY-GROUP | PALLIATIVE CHEMOTHERAPY | Geriatric Assessment | Age Factors | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Tegafur - adverse effects | Tegafur - therapeutic use | Oxonic Acid - administration & dosage | Oxonic Acid - adverse effects | Oxonic Acid - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Research Design | Drug Combinations | Antimitotic agents | Care and treatment | Cancer patients | Chemotherapy | Colorectal cancer | Clinical trials | Aged patients | Metastasis | Drug therapy, Combination | Antineoplastic agents | Cancer | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Cancer and Oncology | Cancer och onkologi
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2015, Volume 26, Issue 1, pp. 141 - 148
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 886 - 893
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 99 - 108
Journal Article
Journal Article
Medicine, ISSN 0025-7974, 10/2018, Volume 97, Issue 41, p. e12836
To investigate the treatment effects of gemcitabine plus S-1 (GS) for metastatic pancreatic cancer in our institution. Data from 41 patients with metastatic... 
ORAL S-1 | SURVIVAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | pancreatic cancer | PHASE-II TRIAL | THERAPY | progression-free survival | S-1 | overall survival | COMBINATION CHEMOTHERAPY | gemcitabine | Development and progression | Gemcitabine | Drug therapy | Pancreatic cancer | Patient outcomes
Journal Article
Gastric Cancer, ISSN 1436-3291, 5/2017, Volume 20, Issue 3, pp. 517 - 526
Journal Article
British Journal of Surgery, ISSN 0007-1323, 05/2014, Volume 101, Issue 6, pp. 653 - 660
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 11, pp. 1063 - 1069
Summary Background The best chemotherapy regimen for metastatic gastric cancer is uncertain, but promising findings have been reported with irinotecan plus... 
Hematology, Oncology and Palliative Medicine | SUPPORTIVE CARE | 5-FLUOROURACIL | ONCOLOGY | HIGH-DOSE METHOTREXATE | DOXORUBICIN | ADVANCED ESOPHAGOGASTRIC CANCER | COOPERATIVE GROUP | EUROPEAN-ORGANIZATION | 1ST-LINE THERAPY | III TRIAL | CHEMOTHERAPY | Japan - epidemiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - secondary | Cisplatin - administration & dosage | Young Adult | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Time Factors | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Drug Administration Schedule | Risk Assessment | Administration, Oral | Tegafur - adverse effects | Tegafur - therapeutic use | Proportional Hazards Models | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Oxonic Acid - adverse effects | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Infusions, Intravenous | Stomach Neoplasms - mortality | Drug Combinations | Adenocarcinoma - mortality | Chemotherapy | Oncology, Experimental | Information services | Research | Metastasis | Stomach cancer | Information services industry | Cancer | Fluorouracil | Index Medicus
Journal Article